Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IMIPRAMINE vs INAVOLISIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IMIPRAMINE vs INAVOLISIB: Safety Overview

Metric IMIPRAMINE INAVOLISIB
Total FAERS Reports 1,077 188
Deaths Reported 242 6
Death Rate 22.5% 3.2%
Hospitalizations 338 60
Average Patient Age 50.3 yrs 62.1 yrs
% Female Patients 59.4% 99.4%
FDA Approval Date Approved Prior to Jan 1, 1982 Oct 10, 2024
Manufacturer Advanced Rx Pharmacy of Tennessee, LLC Genentech, Inc.
Route ORAL ORAL
Marketing Status Discontinued Prescription